MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

NxStage Medical Company Profile (NASDAQ:NXTM)

Consensus Ratings for NxStage Medical (NASDAQ:NXTM) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.50 (57.34% upside)

Analysts' Ratings History for NxStage Medical (NASDAQ:NXTM)
Show:
DateFirmActionRatingPrice TargetActions
2/27/2015Canaccord GenuityBoost Price TargetBuy$24.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/30/2014Canaccord GenuityReiterated RatingBuy$20.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Piper JaffrayBoost Price Target$16.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Canaccord GenuityBoost Price TargetBuy$19.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2014Canaccord GenuityReiterated RatingBuy$21.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2014Wells Fargo & Co.DowngradeMarket Perform -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/28/2014Jefferies GroupBoost Price Target$13.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014Leerink SwannBoost Price Target$15.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014Canaccord GenuityBoost Price Target$18.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/8/2013Piper JaffrayLower Price TargetOverweight$16.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/8/2013Jefferies GroupLower Price TargetBuy$16.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/8/2013Canaccord GenuityBoost Price TargetBuy$17.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2013Canaccord GenuityBoost Price TargetBuy$16.50 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2013Lazard Capital MarketsDowngradeBuy -> Neutral$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/7/2013 forward)